1)Angrisani L, Santonicos A, Iovino P, et al. Bariatric Surgery Worldwide 2013. Obes Surg. 2015 Apr 4. [Epub ahead of print]
|
|
|
2)Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity : a systematic review and meta-analysis or randomized controlled trials. BMJ. 2013; 347: f5934
|
|
|
3)太田正之,猪股雅史,北野正剛.肥満症外科治療の展望: メタボリックサージェリー.肥満研究.2015; 21: 20-6
|
|
|
4)Kasama K, Tagaya N, Kanehira E, at al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009; 19: 1341-5
|
|
|
5)関 洋介,笠間和典.腹腔鏡下スリーブ状胃切除術+十二指腸バイパス術(スリーブバイパス術)の手術手技と効果.月刊糖尿病.2014; 6: 60-5
|
|
|
6)Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013; 32: 427-36
|
|
|
7)日本肥満症治療学会肥満外科治療ガイドライン策定委員会.日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン.2013年版.http://plaza.umin.ne.jp/jsto/gakujutsu/updata/surgery_guideline_2013.pdf
|
|
|
8)Couzin J. Medicine. Bypassing medicine to treat diabetes. Science. 2008; 320: 438-40
|
|
|
9)Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222: 339-52
|
|
|
10)Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference. Recommendation for the evaluation and use of gastrointestinal surgery to treat type2 diabetes mellitus. Ann Surg. 2010; 251: 399-405
|
|
|
11)Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002; 346: 1623-30
|
|
|
12)Rubino F, Marescaux J. Effect of duodenal-jejunalexclusion in a non-obese animal model of type 2 diabetes. A new perspective for an old disease. Ann Surg. 2004; 239: 1-11
|
|
|
13)Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009; 58: 1400-7
|
|
|
14)Watanabe M, Houten SM, Wang L, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest. 2004; 113: 1408-18
|
|
|
15)Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006; 439: 484-9
|
|
|
16)Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014; 509: 183-8
|
|
|
17)Kohli R, Setchell KD, Kirby M, et al. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology. 2013; 154: 2341-51
|
|
|
18)Turnbaugh PJ, Ley RE, Mathowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444: 1027-31
|
|
|
19)Kong LC, Tap J, Aron-Wisnewsky J, et al. Gut microbiota after gastric bypass in human obesity: increased richness and association of bacterial genera with adipose tissue genes. Am J Clin Nutr. 2013; 98: 16-24
|
|
|
20)Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009; 106: 2365-70
|
|
|
21)Goncalves D, Barataud A, De Vadder F, et al. Bile Routing Modification Reproduces Key Features of Gastric Bypass in Rat. Ann Surg. 2015 Jan 8. [Epub ahead of print]
|
|
|
22)Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery : age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013; 9: 379-84
|
|
|
23)Lee WJ, Hur KY, et al. Metabolic Surgery ABCD score: Predicting the Success of Surgical Treatment Diabetes. Obes Surg. 2013; 23: 1020
|
|
|
24)Lee WJ, Almulaifi A, Tsou JJ, et al. Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD score. Surg Obes Relat Dis. 2015; 11: 991-6
|
|
|
25)Lee WJ, Almulaifi A, Tsou JJ, et al. Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015. [Epub ahead of print]
|
|
|